Global and United States Substance Abuse Therapeutics Market Report & Forecast 2023-2028

Report ID: 1829787 | Published Date: Sep 2024 | No. of Page: 88 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Substance Abuse Therapeutics Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Substance Abuse Therapeutics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Substance Abuse Therapeutics Market Size for the Year 2017-2028
        1.2.2 Global Substance Abuse Therapeutics Market Size for the Year 2017-2028
    1.3 Substance Abuse Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Substance Abuse Therapeutics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Substance Abuse Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Substance Abuse Therapeutics Market Dynamics
        1.4.1 Substance Abuse Therapeutics Industry Trends
        1.4.2 Substance Abuse Therapeutics Market Drivers
        1.4.3 Substance Abuse Therapeutics Market Challenges
        1.4.4 Substance Abuse Therapeutics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Substance Abuse Therapeutics by Type
    2.1 Substance Abuse Therapeutics Market Segment by Type
        2.1.1 Opioid Addiction
        2.1.2 Tobacco/Nicotine Addiction
        2.1.3 Alcohol Dependence
    2.2 Global Substance Abuse Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Substance Abuse Therapeutics Market Size by Type (2017-2028)
    2.4 United States Substance Abuse Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Substance Abuse Therapeutics Market Size by Type (2017-2028)
3 Substance Abuse Therapeutics by Application
    3.1 Substance Abuse Therapeutics Market Segment by Application
        3.1.1 Hospital & Clinics
        3.1.2 Residential (non-hospital)
    3.2 Global Substance Abuse Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Substance Abuse Therapeutics Market Size by Application (2017-2028)
    3.4 United States Substance Abuse Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Substance Abuse Therapeutics Market Size by Application (2017-2028)
4 Global Substance Abuse Therapeutics Competitor Landscape by Company
    4.1 Global Substance Abuse Therapeutics Market Size by Company
        4.1.1 Top Global Substance Abuse Therapeutics Companies Ranked by Revenue (2021)
        4.1.2 Global Substance Abuse Therapeutics Revenue by Player (2017-2022)
    4.2 Global Substance Abuse Therapeutics Concentration Ratio (CR)
        4.2.1 Substance Abuse Therapeutics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Substance Abuse Therapeutics in 2021
        4.2.3 Global Substance Abuse Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Substance Abuse Therapeutics Headquarters, Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Substance Abuse Therapeutics Headquarters and Area Served
        4.3.2 Global Substance Abuse Therapeutics Companies Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Substance Abuse Therapeutics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Substance Abuse Therapeutics Market Size by Company
        4.5.1 Top Substance Abuse Therapeutics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Substance Abuse Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Substance Abuse Therapeutics Market Size by Region
    5.1 Global Substance Abuse Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Substance Abuse Therapeutics Market Size by Region (2017-2028)
        5.2.1 Global Substance Abuse Therapeutics Market Size by Region: 2017-2022
        5.2.2 Global Substance Abuse Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Substance Abuse Therapeutics Market Size YoY Growth 2017-2028
        6.1.2 North America Substance Abuse Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Substance Abuse Therapeutics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Substance Abuse Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Substance Abuse Therapeutics Market Size YoY Growth 2017-2028
        6.3.2 Europe Substance Abuse Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Substance Abuse Therapeutics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Substance Abuse Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Substance Abuse Therapeutics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Substance Abuse Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Indivior
        7.1.1 Indivior Company Details
        7.1.2 Indivior Business Overview
        7.1.3 Indivior Substance Abuse Therapeutics Introduction
        7.1.4 Indivior Revenue in Substance Abuse Therapeutics Business (2017-2022)
        7.1.5 Indivior Recent Development
    7.2 Pfizer
        7.2.1 Pfizer Company Details
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Substance Abuse Therapeutics Introduction
        7.2.4 Pfizer Revenue in Substance Abuse Therapeutics Business (2017-2022)
        7.2.5 Pfizer Recent Development
    7.3 Alkermes
        7.3.1 Alkermes Company Details
        7.3.2 Alkermes Business Overview
        7.3.3 Alkermes Substance Abuse Therapeutics Introduction
        7.3.4 Alkermes Revenue in Substance Abuse Therapeutics Business (2017-2022)
        7.3.5 Alkermes Recent Development
    7.4 Novartis
        7.4.1 Novartis Company Details
        7.4.2 Novartis Business Overview
        7.4.3 Novartis Substance Abuse Therapeutics Introduction
        7.4.4 Novartis Revenue in Substance Abuse Therapeutics Business (2017-2022)
        7.4.5 Novartis Recent Development
    7.5 Mylan
        7.5.1 Mylan Company Details
        7.5.2 Mylan Business Overview
        7.5.3 Mylan Substance Abuse Therapeutics Introduction
        7.5.4 Mylan Revenue in Substance Abuse Therapeutics Business (2017-2022)
        7.5.5 Mylan Recent Development
    7.6 Cipla
        7.6.1 Cipla Company Details
        7.6.2 Cipla Business Overview
        7.6.3 Cipla Substance Abuse Therapeutics Introduction
        7.6.4 Cipla Revenue in Substance Abuse Therapeutics Business (2017-2022)
        7.6.5 Cipla Recent Development
    7.7 Glenmark
        7.7.1 Glenmark Company Details
        7.7.2 Glenmark Business Overview
        7.7.3 Glenmark Substance Abuse Therapeutics Introduction
        7.7.4 Glenmark Revenue in Substance Abuse Therapeutics Business (2017-2022)
        7.7.5 Glenmark Recent Development
    7.8 Dr. Reddy's Laboratories
        7.8.1 Dr. Reddy's Laboratories Company Details
        7.8.2 Dr. Reddy's Laboratories Business Overview
        7.8.3 Dr. Reddy's Laboratories Substance Abuse Therapeutics Introduction
        7.8.4 Dr. Reddy's Laboratories Revenue in Substance Abuse Therapeutics Business (2017-2022)
        7.8.5 Dr. Reddy's Laboratories Recent Development
    7.9 Teva Pharmaceutical
        7.9.1 Teva Pharmaceutical Company Details
        7.9.2 Teva Pharmaceutical Business Overview
        7.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Introduction
        7.9.4 Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2017-2022)
        7.9.5 Teva Pharmaceutical Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Substance Abuse Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Substance Abuse Therapeutics Market Trends
    Table 3. Substance Abuse Therapeutics Market Drivers
    Table 4. Substance Abuse Therapeutics Market Challenges
    Table 5. Substance Abuse Therapeutics Market Restraints
    Table 6. Global Substance Abuse Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Substance Abuse Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Substance Abuse Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Substance Abuse Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Substance Abuse Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Substance Abuse Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Substance Abuse Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global Substance Abuse Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Substance Abuse Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Substance Abuse Therapeutics as of 2021)
    Table 15. Top Players of Substance Abuse Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Substance Abuse Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Substance Abuse Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Substance Abuse Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Substance Abuse Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Substance Abuse Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Substance Abuse Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Substance Abuse Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Substance Abuse Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Substance Abuse Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Substance Abuse Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Substance Abuse Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Substance Abuse Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Indivior Company Details
    Table 31. Indivior Business Overview
    Table 32. Indivior Substance Abuse Therapeutics Product
    Table 33. Indivior Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. Indivior Recent Development
    Table 35. Pfizer Company Details
    Table 36. Pfizer Business Overview
    Table 37. Pfizer Substance Abuse Therapeutics Product
    Table 38. Pfizer Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. Pfizer Recent Development
    Table 40. Alkermes Company Details
    Table 41. Alkermes Business Overview
    Table 42. Alkermes Substance Abuse Therapeutics Product
    Table 43. Alkermes Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. Alkermes Recent Development
    Table 45. Novartis Company Details
    Table 46. Novartis Business Overview
    Table 47. Novartis Substance Abuse Therapeutics Product
    Table 48. Novartis Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Novartis Recent Development
    Table 50. Mylan Company Details
    Table 51. Mylan Business Overview
    Table 52. Mylan Substance Abuse Therapeutics Product
    Table 53. Mylan Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. Mylan Recent Development
    Table 55. Cipla Company Details
    Table 56. Cipla Business Overview
    Table 57. Cipla Substance Abuse Therapeutics Product
    Table 58. Cipla Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. Cipla Recent Development
    Table 60. Glenmark Company Details
    Table 61. Glenmark Business Overview
    Table 62. Glenmark Substance Abuse Therapeutics Product
    Table 63. Glenmark Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. Glenmark Recent Development
    Table 65. Dr. Reddy's Laboratories Company Details
    Table 66. Dr. Reddy's Laboratories Business Overview
    Table 67. Dr. Reddy's Laboratories Substance Abuse Therapeutics Product
    Table 68. Dr. Reddy's Laboratories Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million)
    Table 69. Dr. Reddy's Laboratories Recent Development
    Table 70. Teva Pharmaceutical Company Details
    Table 71. Teva Pharmaceutical Business Overview
    Table 72. Teva Pharmaceutical Substance Abuse Therapeutics Product
    Table 73. Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2017-2022) & (US$ Million)
    Table 74. Teva Pharmaceutical Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Substance Abuse Therapeutics Product Picture
    Figure 2. Global Substance Abuse Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Substance Abuse Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Substance Abuse Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Substance Abuse Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Substance Abuse Therapeutics Market Share in Global 2017-2028
    Figure 7. Substance Abuse Therapeutics Report Years Considered
    Figure 8. Product Picture of Opioid Addiction
    Figure 9. Product Picture of Tobacco/Nicotine Addiction
    Figure 10. Product Picture of Alcohol Dependence
    Figure 11. Global Substance Abuse Therapeutics Market Share by Type in 2022 & 2028
    Figure 12. Global Substance Abuse Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Substance Abuse Therapeutics Market Share by Type (2017-2028)
    Figure 14. United States Substance Abuse Therapeutics Market Share by Type in 2022 & 2028
    Figure 15. United States Substance Abuse Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Substance Abuse Therapeutics Market Share by Type (2017-2028)
    Figure 17. Product Picture of Hospital & Clinics
    Figure 18. Product Picture of Residential (non-hospital)
    Figure 19. Global Substance Abuse Therapeutics Market Share by Application in 2022 & 2028
    Figure 20. Global Substance Abuse Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Substance Abuse Therapeutics Market Share by Application (2017-2028)
    Figure 22. United States Substance Abuse Therapeutics Market Share by Application in 2022 & 2028
    Figure 23. United States Substance Abuse Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Substance Abuse Therapeutics Market Share by Application (2017-2028)
    Figure 25. North America Substance Abuse Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Substance Abuse Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Substance Abuse Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Substance Abuse Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Substance Abuse Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Substance Abuse Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Indivior Revenue Growth Rate in Substance Abuse Therapeutics Business (2017-2022)
    Figure 54. Pfizer Revenue Growth Rate in Substance Abuse Therapeutics Business (2017-2022)
    Figure 55. Alkermes Revenue Growth Rate in Substance Abuse Therapeutics Business (2017-2022)
    Figure 56. Novartis Revenue Growth Rate in Substance Abuse Therapeutics Business (2017-2022)
    Figure 57. Mylan Revenue Growth Rate in Substance Abuse Therapeutics Business (2017-2022)
    Figure 58. Cipla Revenue Growth Rate in Substance Abuse Therapeutics Business (2017-2022)
    Figure 59. Glenmark Revenue Growth Rate in Substance Abuse Therapeutics Business (2017-2022)
    Figure 60. Dr. Reddy's Laboratories Revenue Growth Rate in Substance Abuse Therapeutics Business (2017-2022)
    Figure 61. Teva Pharmaceutical Revenue Growth Rate in Substance Abuse Therapeutics Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
Frequently Asked Questions
Substance Abuse Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Substance Abuse Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Substance Abuse Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Golf Travel

Golf Travel market is segmented by region (country), players, by Type and by Application. Players ... Read More

Coconut Products

Coconut Products market is segmented by region (country), players, by Type and by Application. Pl ... Read More